>https://youtu.be/Tq8SXOBy-4w
There doesn't seem to be much on MSM about this matter, but the way this guy describes it, makes it seem to be pretty much a cure for SARS-COV-2. I'm skeptical, and have looked up a few studies saying the drug is beneficial in-vitro, while also potentially having an effect in interventional treatments.
The NIH's stance on Ivermectin is currently:
>Ivermectin has been shown to inhibit the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cell cultures.7 However, pharmacokinetic and pharmacodynamic studies suggest that achieving the plasma concentrations necessary for the antiviral efficacy detected in vitro would require administration of doses up to 100-fold higher than those approved for use in humans.8,9 Even though ivermectin appears to accumulate in the lung tissue, predicted systemic plasma and lung tissue concentrations are much lower than 2 µM, the half-maximal inhibitory concentration (IC50) against SARS-CoV-2 in vitro.10,11
As of now, a double-blind randomized study is being observed on people infected with SARS-COV-2, which is slated to be completed in March 2021
>clinicaltrials.gov/ct2/show/NCT04602507
What I want to know from you, is your interpretation of the available data, as well as your general thoughts on Dr Kory, the man who has been spearheading this issue. Do you consider him to be acting on good faith? Do you predict treatment with Ivermectin will begin at some point, or will vaccines continue to be part of the official guidelines/recommendations for the SARS-COV-2 pandemic?
There doesn't seem to be much on MSM about this matter, but the way this guy describes it, makes it seem to be pretty much a cure for SARS-COV-2. I'm skeptical, and have looked up a few studies saying the drug is beneficial in-vitro, while also potentially having an effect in interventional treatments.
The NIH's stance on Ivermectin is currently:
>Ivermectin has been shown to inhibit the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cell cultures.7 However, pharmacokinetic and pharmacodynamic studies suggest that achieving the plasma concentrations necessary for the antiviral efficacy detected in vitro would require administration of doses up to 100-fold higher than those approved for use in humans.8,9 Even though ivermectin appears to accumulate in the lung tissue, predicted systemic plasma and lung tissue concentrations are much lower than 2 µM, the half-maximal inhibitory concentration (IC50) against SARS-CoV-2 in vitro.10,11
As of now, a double-blind randomized study is being observed on people infected with SARS-COV-2, which is slated to be completed in March 2021
>clinicaltrials.gov/ct2/show/NCT04602507
What I want to know from you, is your interpretation of the available data, as well as your general thoughts on Dr Kory, the man who has been spearheading this issue. Do you consider him to be acting on good faith? Do you predict treatment with Ivermectin will begin at some point, or will vaccines continue to be part of the official guidelines/recommendations for the SARS-COV-2 pandemic?
